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Abstract Syntaxin 1 and synaptobrevin play an essential role in
synaptic vesicle exocytosis. Two isoforms for each of these
proteins, syntaxin 1A and 1B and synaptobrevin 1 and 2, have
been found in nerve endings. Previous morphological studies have
revealed a characteristic co-localization of syntaxin 1 and
synaptobrevin isoforms in nervous and endocrine systems;
however, the physiological significance of differential distribution
is not known. In the present study an in vitro assay has been used
to study a possible isoform specific interaction between syntaxin
and synaptobrevin isoforms. The results show that although both
syntaxin 1A and 1B may interact with synaptobrevin 1 and 2, this
interaction is not uniform, showing different affinity patterns
depending on the syntaxin 1/synaptobrevin isoform combination.
The addition of SNAP-25 increased the binding capacity of
syntaxin and synaptobrevin isoforms without affecting specific
interactions.
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1. Introduction
It is well established that regulated exocytosis is a process
mediated by a series of protein-protein interactions. Soluble
factors such as N-ethylmaleimide sensitive factor (NSF) and
K,L-SNAPs (soluble NSF attachment proteins) interact with
complexes composed of proteins located at the vesicle mem-
brane (v-SNARE, vesicle-SNAP receptors) and at the target
membrane (t-SNARE, target-SNAP receptors) in the process
of membrane targeting, fusion and/or retrieval [1,2]. Although
the exact sequence of events that take place between soluble
factors and SNARE proteins is still a matter for discussion
[3], it has been demonstrated that the direct binding between
v- and t-SNARE is fundamental for the fusion of membrane
compartments (i.e. synaptic vesicles and presynaptic plasma
membrane) and that it might also be required for proper
membrane compartment recognition and docking [1,4]. Syn-
taxin 1 and synaptosomal associated protein of 25 kDa
(SNAP-25) are two pre-synaptic membrane proteins capable
of binding speci¢c vesicle membrane proteins [5^9]. It is well
established that syntaxin 1, SNAP-25 and synaptobrevin (also
known as vesicle associated membrane protein, VAMP) form
an SDS-resistant protein complex of 7s that acts in the later
steps of synaptic vesicle fusion with the plasma membrane
[1,2,10]. In addition, the fact that these SNARE proteins are
the molecular targets of clostridial neurotoxins, which selec-
tively block neurotransmitter release, highlights their func-
tional importance in synaptic transmission [11]. At least two
isoforms for each of these SNARE proteins have been found
in nerve terminals (SNAP-25 a and b; syntaxin 1A and 1B;
synaptobrevin 1 and 2) [12,13]. However, the functional sig-
ni¢cance of the existence of more than one SNARE isoform
in nerve terminals is still unknown. Morphological studies
have shown a di¡erential distribution of syntaxin and synap-
tobrevin isoforms in some areas of the central and peripheral
nervous system. Interestingly, syntaxin 1A and 1B are usually
co-localized with synaptobrevin 2 and synaptobrevin 1, re-
spectively [14^16]. Moreover, endocrine cells express syntaxin
1A and synaptobrevin 2 but not syntaxin 1B nor synaptobre-
vin 1 [17,18]. To date, no functional signi¢cance has been
assigned to speci¢c syntaxin and synaptobrevin isoform asso-
ciations and the role that SNAP-25 may play in these inter-
actions.
In vitro protein-protein interaction assays have been useful
to study the functional aspects of SNARE protein interactions
[6,19,20]. These assays have been outstanding in de¢ning the
minimum domains involved in the SNARE complex [4,20]
and elucidating the three-dimensional structure of the com-
plex core [21]. In the present work, an in vitro assay using
recombinant SNARE proteins was used to study speci¢c iso-
form interactions. We show relevant di¡erences in a⁄nities of
the interaction between syntaxin and synaptobrevin isoforms,
even though both syntaxin isoforms can bind to each synap-
tobrevin isoform. The addition of recombinant SNAP-25 to
the assay increases the a⁄nity between syntaxin and synapto-
brevin isoforms.
The present results agree with the di¡erential syntaxin and
synaptobrevin isoform distributions observed in the endocrine
system and some areas of the nervous system [14^16,18]. In
addition, the e¡ect of the recombinant SNAP-25 on the syn-
taxin and synaptobrevin isoform bindings supports a possible
in vivo facilitative function for this protein in the assembly of
the 7s complex core [4,10,21].
2. Materials and methods
2.1. Materials
Synaptobrevin 1 and 2 cDNAs were obtained by reverse transcrip-
tion-polymerase chain reaction (RT-PCR, Pharmacia Biotech) from
rat brain according to the manufacturer’s protocol. 5P-TCATTACA-
GATTTAGGAGG-3P and 5P-TTTAGGAACCCTCAACC-3P were
used as sense and antisense primers, respectively, for synaptobrevin
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1, while 5P-GGTTGAGGGTTCTAAAG-3P and 5P-CTTGAGGTTT-
TTCCACCA-3P were used for synaptobrevin 2. BamHI and EcoRI
restriction sites were introduced in the sense and antisense primers,
respectively, to facilitate subcloning of the ampli¢ed DNA sequences.
SNAP-25b (S25b) cDNA was obtained as previously described [22].
DNA with the sequences encoding the cytosolic regions of syntaxin
(Stx) 1A and 1B were introduced into pTRCHis (His)6 fusion protein
expression vector (Invitrogen) as previously described [14].
2.2. Fusion proteins
Glutathione S-transferase (GST-)-synaptobrevin isoforms (1 and 2)
and SNAP-25b cDNAs encoding the respective full protein sequences
were cloned into pGEX 4T-1 GST fusion protein expression vector
(Pharmacia). GST and the GST fusion proteins were expressed in the
Bl 21 DE3 pLys Escherichia coli strain after isopropyl L-D-thiogalac-
topyranoside (IPTG) induction (2 mM). The cells were centrifuged at
6000Ug for 20 min and the pellet was resuspended in ice-cold phos-
phate bu¡ered saline (PBS) with 1% Triton X-100, sonicated and
centrifuged at 12 000Ug for 30 min. The resulting supernatants
were incubated at 4‡C for 1 h with glutathione Sepharose beads
(Pharmacia) previously equilibrated in PBS bu¡er. After incubation,
the beads were washed three times with PBS and kept in the same
bu¡er at 4‡C until use. SNAP-25 was further puri¢ed by incubating
the glutathione Sepharose beads containing GST-SNAP-25 with
thrombin (0.02 U/Wl) in bu¡er A (PBS, with 1 mM Cl2Ca). The
cytosolic fragments of (His)6-Stx 1A and 1B were expressed in TOP
10 E. coli strain, after induction with IPTG (2 mM). The cells were
centrifuged, resuspended, disrupted and centrifuged as above. Super-
natants were applied to Ni-NTA agarose (Qiagen) containing columns
and the attached proteins were eluted with a 50^300 mM imidazole
gradient. To eliminate imidazole, the fractions containing the re-
combinant proteins were applied to desalting columns (Bio-Rad) pre-
viously equilibrated with PBS bu¡er. The concentration of recombi-
nant proteins was de¢ned after protein quanti¢cation by the
bicinchoninic acid (BCA) method (Pierce). The purity and the amount
of the recombinant proteins were further analyzed by SDS-PAGE
after staining of the gels with Coomassie blue R-250.
2.3. In vitro binding assay
GST, GST-synaptobrevin 1 and 2 and GST-SNAP-25 fusion pro-
teins (1 mM) previously bound to glutathione-agarose beads were
incubated with bovine serum albumin (BSA, 10 mg/ml) for 60 min
at 4‡C in PBS. After washing with PBS, the beads with GST-synap-
tobrevin 1 or GST-synaptobrevin 2 were incubated overnight at 4‡C
with syntaxin 1A and 1B at di¡erent concentrations (ranging from
4 WM to 139 WM), and in the presence or absence of soluble SNAP-25
(20 WM), as speci¢ed. Each condition point was washed at least three
times with 1 ml of phosphate bu¡er, 20 mM pH 7.4, 300 mM NaCl,
10% glycerol and 0.5% Triton X-100. After washing, SDS-sample
bu¡er was added to the beads, and the proteins were analyzed by
SDS-PAGE and Western blotting. GST coupled to glutathione-agar-
ose beads was used in parallel to determine the non-speci¢c binding.
2.4. Immunoblots
After SDS-PAGE, the proteins were transferred onto nitrocellulose
membranes. The membranes were blocked using 5% non-fat dry milk
in Tris-bu¡ered saline containing 0.1% Tween 20 (TBS), and incu-
bated overnight at 4‡C with anti-syntaxin monoclonal antibody (clone
HPC-1, Sigma) in the same bu¡er. After incubation with the appro-
priate secondary antibodies conjugated to horseradish peroxidase, the
blots were developed using the enhanced chemiluminescence (ECL)
method (Amersham Life Science). The ¢lms were scanned and then
subjected to band densitometry and quanti¢cation (Phoretix System
Software).
3. Results and discussion
3.1. Binding between recombinant SNARE isoforms
An in vitro assay has been performed to study the interac-
tions between recombinant synaptobrevin and syntaxin iso-
forms and the e¡ect of SNAP-25 on such interactions. Similar
approaches have been used in other studies to analyze protein-
protein interactions between SNARE proteins [6,19,23]. In the
¢rst series of experiments, the cytosolic fragments of syntaxin
1A and 1B (18 WM) were incubated separately with GST-syn-
aptobrevin 1 or 2 bound to glutathione-Sepharose beads. In
these experiments the concentration of GST-synaptobrevin 1
or 2 was in excess with respect to syntaxin. The binding of
syntaxins was analyzed by Western blotting using a monoclon-
al antibody (HPC-1 clone), which recognized both syntaxin
1A and 1B isoforms (Fig. 1). Syntaxin 1A and 1B were spe-
ci¢cally bound to GST-synaptobrevin isoforms (no signi¢cant
amount of syntaxins was found when incubated with GST
conjugated to glutathione-Sepharose beads). However, the
amount of syntaxin bound to GST-synaptobrevin was di¡er-
ent depending on the combination of syntaxin and synapto-
brevin isoforms analyzed. Thus, under these conditions, syn-
taxin isoforms showed a greater a⁄nity for synaptobrevin 2
than for synaptobrevin 1. Similar results were obtained with
the inverse experiments: incubating synaptobrevin 1 or 2 with
(His)6-syntaxin 1A or 1B bound to Ni-agarose beads and
analyzing the amount of synaptobrevin bound to (His)6-syn-
taxin-Ni-agarose beads (data not shown).
These results suggest that although all four isoforms may
coexist in the same areas of the nervous systems (and at the
same nerve terminals), a speci¢c combination of isoforms may
improve e⁄ciency in the formation of protein core complex
(7s) essential for vesicle exocytosis.
3.2. Di¡erential binding a⁄nity between syntaxin 1A and 1B,
and synaptobrevin 1 and 2
To determine if the di¡erential patterns of syntaxin iso-
forms recovered from the binding to GST-synaptobrevin 1
or 2 were dependent on protein concentration, we performed
the same experiment using di¡erent syntaxin concentrations
(ranging from 4 to 32 WM). Densitometric analysis of Western
blots for syntaxin corroborated the previous qualitative data
showing the di¡erential binding patterns in the syntaxin 1/
Fig. 1. GST and GST-synaptobrevin 1 and 2 (GST-V1 and GST-
V2) were bound to glutathione-Sepharose beads and incubated with
18 WM (His)6-syntaxin 1A and 1B. A: The amount of syntaxin
bound to the beads was analyzed by SDS-PAGE and Western blot-
ting using the monoclonal HPC-1 antibody (1:1000) and ECL meth-
od. B: Ponceau staining of the nitrocellulose membranes containing
GST (V23 kDa) and GST-synaptobrevin 1 and 2 (V41 kDa).
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synaptobrevin combinations tested (Fig. 2). Thus, syntaxin 1A
has a higher binding capacity to synaptobrevin 2 than synap-
tobrevin 1. Syntaxin 1B interaction with synaptobrevin iso-
forms seems to be di¡erent. The a⁄nity of recombinant syn-
taxin 1B to GST-synaptobrevins could vary in a
concentration-dependent manner. At the lower concentration
tested, syntaxin 1B binding was more e¡ective to synaptobre-
vin 2 than synaptobrevin 1 (similar to syntaxin 1A, see
above). Nevertheless, this situation changed when the syntaxin
1B concentration was increased. At the higher concentrations,
the binding of syntaxin 1B to synaptobrevin 2 decreased com-
pared to the syntaxin 1B/synaptobrevin 1 combination. There-
fore, at higher syntaxin 1B concentrations, there was a higher
a⁄nity to synaptobrevin 1 than to synaptobrevin 2.
These results suggest speci¢c functional interaction for the
isoforms of syntaxin 1 and synaptobrevin as well as a possible
explanation for previous morphological observations. Ac-
tually, the fact that recombinant syntaxin 1A has a higher
binding capacity for synaptobrevin 2 than for synaptobrevin
1 agrees with the co-localization of syntaxin 1A and synapto-
Fig. 2. GST-synaptobrevin 1 and 2 (GST-VAMP 1-2) bound to glutathione-Sepharose beads were incubated with increasing concentrations of
(His)6-syntaxin 1A and 1B (Stx 1A/1B) in the presence or absence of SNAP-25 (20 WM). A: The amount of syntaxin bound to the beads was
detected by SDS-PAGE and Western blotting using the monoclonal antibody HPC-1 (1:1000) and the ECL method. B: Densitometric analysis
from a representative experiment of the amount of syntaxin 1 bound to glutathione-Sepharose-GST-synaptobrevin in the presence (open circles)
or absence (¢lled circles) of SNAP-25.
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brevin 2 in some areas of the nervous and the endocrine
systems [14^18].
Di¡erences in syntaxin 1 and synaptobrevin distribution
and concentration throughout the nervous system [14^16],
together with the di¡erent a⁄nity pattern of syntaxin 1A
and 1B for synaptobrevin isoforms, point to a possible syn-
taxin 1B and 1A preponderant role in di¡erent neural net-
works or nerve terminals. Neurons secrete neurotransmitters
and neuropeptides by exocytosis of small synaptic vesicles
(SVs) and large dense core vesicles (LDCVs). SV exocytosis
has been associated with fast neurosecretion of classical neu-
rotransmitters (glutamate, acetylcholine), whereas LDCVs are
responsible for substances with a neuromodulatory action
(neuropeptides, norepinephrine, etc.). In spite of di¡erences
in content, localization in the nerve terminal, and sensitivity
to calcium levels for exocytosis, both sets of secretory organ-
elles contain the molecular machinery for regulated exocyto-
sis, including SNARE proteins, synaptotagmin and Rab3a,
among others. It has been suggested that the di¡erences in
sensitivity to calcium concentrations of SV and LDCV can
be explained by the existence of di¡erent synaptotagmin iso-
forms [24], voltage gated calcium channel isoform diversity
[25] and the di¡erential distribution inside the nerve terminal
of SVs and LDCVs. In any case, in addition to the presence of
di¡erent protein isoforms related to the entry and detection of
calcium inside nerve terminals, the presence of the precise
combination of SNARE isoform proteins that form part of
the exocytotic machinery would be required for a high e⁄-
ciency of SV and/or LDCV exocytosis. According to these
results, syntaxin 1B would be mainly involved in neuronal
networks which need a very concrete amount of neurotrans-
mitter liberated in a short time. Conversely, syntaxin 1A could
be related to a more regulated but slower neurosecretion, for
example in those systems involved in neuropeptide and hor-
mone secretion. Supporting this suggestion, it has been found
that neuromuscular junction, considered a fast synapsis, only
contains syntaxin 1B and synaptobrevin 1, whereas cells of the
endocrine system with peptide secretion only express syntaxin
1A and synaptobrevin 2 [16^18].
In addition to the existence of proteins that interact with
syntaxin 1 and synaptobrevin and that may regulate their
availability to form the 7s protein core complex required for
exocytosis [26,27], the di¡erent binding capacity of syntaxin 1
isoforms to synaptobrevin isoforms suggests the presence of a
di¡erential self-regulated process for the core complex forma-
tion before calcium entry and neurotransmitter release.
3.3. SNAP-25 increases binding without changing the a⁄nity
pattern
In the next step, di¡erent concentrations of cytosolic frag-
ments of recombinant syntaxin isoforms were incubated with
both recombinant GST-synaptobrevin isoforms in the absence
or the presence of recombinant SNAP-25 to determine the
e¡ect of SNAP-25 on syntaxin-binding isoforms to synapto-
brevin isoforms. The amount of syntaxin bound was deter-
mined by Western blotting and densitometric analysis.
The addition of SNAP-25 to the assay increased the
amount of syntaxin 1A and 1B bound to GST-synaptobrevin
isoforms, but maintained the previously observed isoform spe-
ci¢city (Fig. 2). To further investigate the nature of the in-
crease in the binding of syntaxin 1 to synaptobrevin isoforms
in the presence of SNAP-25, we decided to incubate increasing
concentrations of syntaxin isoforms with GST-SNAP-25
bound to glutathione-agarose beads and to analyze the
amount of syntaxin bound by Western blotting. In this case,
no signi¢cant di¡erence in the binding of both recombinant
syntaxin 1 isoforms to GST-SNAP-25 was found (Fig. 3).
Thus, we could conclude that SNAP-25 does not a¡ect the
isoform-dependent di¡erential formation of syntaxin 1/synap-
tobrevin complexes. These results also suggest that SNAP-25,
besides its speci¢c role in membrane fusion during exocytosis,
enhances the binding of syntaxin 1 to synaptobrevin, and that
this e¡ect is not isoform-dependent.
Therefore, the present results agree with several works that
suggest a possible facilitative role of SNAP-25 in SNARE
complex formation [4,10,21]. So SNAP-25 could help to facil-
itate the proper binding between syntaxin 1 and synaptobre-
vin and to stabilize the 7s complex. In line with the location of
SNAP-25 and syntaxin 1 at the plasma membrane, acting as t-
SNAREs, the present results support a previous suggestion by
Sutton et al. [21] concerning the sequence of the 7s complex
Fig. 3. GST-SNAP-25 bound to glutathione-Sepharose beads was
incubated with increasing concentrations (from 4 to 140 WM) of
(His)6-syntaxin 1 A and 1B. A: Syntaxin 1 bound to the beads was
detected by Western blotting using monoclonal HPC-1 antibody
(1:1000) and the ECL method. B: Densitometric analysis from a
representative experiment of syntaxin 1A (¢lled squares) or syntaxin
1B (open circles) bound to the glutathione-Sepharose-GST-SNAP-
25.
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assembly, that would begin with the formation of an hetero-
dimer complex composed of syntaxin 1 and SNAP-25 fol-
lowed by the binding of synaptobrevin to the t-SNARE com-
plex.
Acknowledgements: We thank T. Yohannan for editorial assistance.
This work was supported by a Grant from DGICYT PM95-0116 and
EU Project BMH4-CT96-1586. We wish to thank T. Yohannan for
editorial assistance. F.P.B. has a fellowship from MEC (Spain).
References
[1] Trimble, W.S. (1998) Synaptic Vesicle Proteins: A Molecular
Study in Secretory Systems and Toxins, pp. 3^62, Harwood Aca-
demic Publishers, New York.
[2] Hanson, P.I., Heuser, J.E. and Jahn, R. (1997) Curr. Opin. Neu-
robiol. 7, 310^315.
[3] Weis, W.I. and Scheller, R.H. (1998) Nature 395, 328^329.
[4] Weber, T., Zemelman, B.V., McNew, J.A., Westermann, B.,
Gmachl, M., Parlati, F., Sollner, T.H. and Rothman, J.E.
(1998) Cell 92, 759^772.
[5] Bennett, M.K., Calakos, N. and Scheller, R.H. (1992) Science
257, 255^259.
[6] Calakos, N., Bennett, M.K., Peterson, K.E. and Scheller, R.H.
(1994) Science 263, 1146^1149.
[7] Schiavo, G., Stenbeck, G., Rothman, J.E. and Sollner, T.H.
(1997) Proc. Natl. Acad. Sci. USA 94, 997^1001.
[8] Fujita, Y., Shirataki, H., Sakisaka, T., Asakura, T., Ohya, T.,
Kotani, H., Yokoyama, S., Nishioka, H., Matsuura, Y., Mizo-
guchi, A., Scheller, R.H. and Takai, Y. (1998) Neuron 20, 905^
915.
[9] Sheng, Z.H., Westenbroek, R.E. and Catterall, W.A. (1998)
J. Bioenerg. Biomembr. 30, 335^345.
[10] Lin, R.C. and Scheller, R.H. (1997) Neuron 19, 1087^1094.
[11] Niemann, H., Blasi, J. and Jahn, R. (1994) Trends Cell Biol. 4,
179^185.
[12] Sudhof, T.C. (1995) Nature 375, 645^653.
[13] Ferro-Novick, S. and Jahn, R. (1994) Nature 370, 191^193.
[14] Ruiz-Montasell, B., Aguado, F., Majo, G., Chapman, E.R., Ca-
nals, J.M., Marsal, J. and Blasi, J. (1996) Eur. J. Neurosci. 8,
2544^2552.
[15] Aguado, F., Majo¤, G., Ruiz-Montasell, B., Llorens, J., Marsal, J.
and Blasi, J. (1999) Neuroscience 88, 437^446.
[16] Li, J.Y., Edelmann, L., Jahn, R. and Dahlstrom, A. (1996)
J. Neurosci. 16, 137^147.
[17] Aguado, F., Majo, G., Ruiz-Montasell, B., Canals, J.M., Casa-
nova, A., Marsal, J. and Blasi, J. (1996) Eur. J. Cell Biol. 69,
351^359.
[18] Jacobsson, G., Bean, A.J., Scheller, R.H., Juntti-Berggren, L.,
Deeney, J.T., Berggren, P.O. and Meister, B. (1994) Proc. Natl.
Acad. Sci. USA 91, 12487^12491.
[19] Pevsner, J., Hsu, S.C., Braun, J.E., Calakos, N., Ting, A.E.,
Bennett, K. and Scheller, R.H. (1994) Neuron 13, 353^361.
[20] Fasshauer, D., Eliason, W.K., Brunger, A.T. and Jahn, R. (1998)
Biochemistry 37, 10354^10362.
[21] Sutton, R.B., Fasshauer, D., Jahn, R. and Brunger, A.T. (1998)
Nature 395, 347^353.
[22] Blasi, J., Chapman, E.R., Link, E., Binz, T., Yamasaki, S., De-
Camilli, P., Sudhof, T.C., Niemann, H. and Jahn, R. (1993)
Nature 365, 160^163.
[23] Sollner, T., Bennett, M.K., Whiteheart, S.W., Scheller, R.H. and
Rothman, J.E. (1993) Cell 75, 409^418.
[24] Sudhof, T.C. and Rizo, J. (1996) Neuron 17, 379^388.
[25] Kim, D.K. and Catterall, W.A. (1997) Proc. Natl. Acad. Sci.
USA 94, 14782^14786.
[26] Hallachmi, N. and Lev, Z. (1996) J. Neurochem. 66, 889^897.
[27] Edelmann, L., Hanson, P.I., Chapman, E.R. and Jahn, R. (1995)
EMBO J. 14, 224^231.
FEBS 22564 1-9-99
F. Pe¤rez-Brangul|¤ et al./FEBS Letters 458 (1999) 60^6464
